Canada: For Your Phase 3 Global Trial Expansion
Oncology continues to be the largest and fastest growing therapeutic area in the clinical trials market, and a market dominated…
Doubly Nimble: why you should open global P1 clinical trials in Canada on Day 1
With agility increasingly becoming the most important global driver of success, it’s worth noting that Canadian oncology research center Phase…
Prime Location for Global Clinical Studies?
Canada is considered one of the most attractive places to live in the world, with a high quality of life,…
Why Not Canada for Your Phase 3 Global Trial Expansion?
Pre-pandemic oncology was both the largest and fastest growing therapeutic area in the clinical trials market. A key market trend…
Diversity in Clinical Trial Participants: Canada Holds Promise
Participant diversity in clinical trials can be quite challenging to achieve. With COVID the concern about appropriate demographic representation is…
Let Canada Contribute to Your Basket Trial Success
With the emergence of basket trials in the early-phase oncology setting, clinical research teams are faced with challenges of enrollment…
The Canadian Landscape for Childhood Cancer Research
Pediatric Hematology Oncology is a relatively recent area of study. Only in the past 50 years have substantial advances taken…
Continued Importance of CRAs Supporting Role for Patient Centric Trials
The COVID-19 world-wide pandemic has forced the clinical trial industry to make rapid changes in order to continue protecting participant…
Some Facts About Canada… Mitigate COVID-19 Impact on Your Clinical Trials
People often adhere to a myth and perpetuate it in answer to a difficult question, ending all further inquiry into…
Consider This Region for Your Phase 3 Global Trial
As of May 2020 ClinicalTrials.gov lists 16,150 oncology trials registered as Recruiting, Not yet Recruiting Studies, and the chart below…